Literature DB >> 11923466

The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study.

Masayuki Saitoh1, Ryoichi Takayanagi, Kiminobu Goto, Akiyoshi Fukamizu, Arihiro Tomura, Toshihiko Yanase, Hajime Nawata.   

Abstract

To clarify the physiological significance of the intranuclear speckled distribution, or foci formation, of liganded steroid receptors, the subnuclear distribution of green (GFP), yellow (YFP), and cyan (CFP) fluorescent protein-tagged receptors and coactivators was investigated. The foci formation of 5 alpha-dihydrotestosterone (DHT)-bound AR-GFP in COS7 cells was abolished by the cotransfection of a CBP Delta (118-2393) fragment eliciting a dominant negative effect on the transactivation capacity of the AR. The N-terminal AR fragment (AR-AF-1-YFP), which has a strong constitutive transactivation function, formed foci without DHT, whereas the C-terminal AR fragment (AR-AF-2-CFP), which has a quite low transactivation function, was distributed homogeneously even in the presence of DHT. The reporter gene assay showed a synergism between the transactivation functions of AR-AF-1 and AR-AF-2. This synergism was not reflected by the above two-dimensional imaging. In contrast, a three-dimensional imaging method clearly showed a difference in the intranuclear spatial distribution. The DHT-bound wild-type AR-GFP alone or AR-AF-1-YFP plus DHT-bound AR-AF-2-CFP was distributed as approximately 300 discrete spots in one nucleus, whereas AR-AF-1-YFP alone was distributed as one volume in a reticular pattern. Furthermore, not only AR but also the glucocorticoid receptor-YFP, ER alpha -GFP, and YFP-tagged SRC-1, TIF2, and CBP were found to be accumulated in identical spots in the presence of ligand. All of the above results indicate that CBP is one of the factors essential for foci formation of the AR, and may propose the hypothesis that transcriptionally activated steroid receptors, regardless of the type of receptor, are transferred to common compartments (foci) and form a complex with coactivators, and this process is essential to full transactivation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923466     DOI: 10.1210/mend.16.4.0812

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

1.  A type I DnaJ homolog, DjA1, regulates androgen receptor signaling and spermatogenesis.

Authors:  Kazutoyo Terada; Kentaro Yomogida; Tomoaki Imai; Hiroshi Kiyonari; Naoki Takeda; Tsuyoshi Kadomatsu; Masato Yano; Shinichi Aizawa; Masataka Mori
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

2.  [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application].

Authors:  L von Bernus; P Högger; O Pfaar; L Klimek
Journal:  HNO       Date:  2012-08       Impact factor: 1.284

3.  [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis].

Authors:  L Klimek; P Högger; O Pfaar
Journal:  HNO       Date:  2012-07       Impact factor: 1.284

4.  Nuclear compartmentalization of N-CoR and its interactions with steroid receptors.

Authors:  Yin Wu; Hisaya Kawate; Keizo Ohnaka; Hajime Nawata; Ryoichi Takayanagi
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  Effect of anabolic-androgenic steroids and glucocorticoids on the kinetics of hAR and hGR nucleocytoplasmic translocation.

Authors:  Amy B Cadwallader; Douglas E Rollins; Carol S Lim
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

6.  Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells.

Authors:  T Tanaka; B L Dancheck; L C Trifiletti; R E Birnkrant; B J Taylor; S H Garfield; U Thorgeirsson; L M De Luca
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo.

Authors:  Sarah A Loddick; Sarah J Ross; Andrew G Thomason; David M Robinson; Graeme E Walker; Tom P J Dunkley; Sandra R Brave; Nicola Broadbent; Natalie C Stratton; Dawn Trueman; Elizabeth Mouchet; Fadhel S Shaheen; Vivien N Jacobs; Marie Cumberbatch; Joanne Wilson; Rhys D O Jones; Robert H Bradbury; Alfred Rabow; Luke Gaughan; Chris Womack; Simon T Barry; Craig N Robson; Susan E Critchlow; Stephen R Wedge; A Nigel Brooks
Journal:  Mol Cancer Ther       Date:  2013-07-16       Impact factor: 6.261

8.  Conformation of the c-Fos/c-Jun complex in vivo: a combined FRET, FCCS, and MD-modeling study.

Authors:  György Vámosi; Nina Baudendistel; Claus-Wilhelm von der Lieth; Nikoletta Szalóki; Gábor Mocsár; Gabriele Müller; Péter Brázda; Waldemar Waldeck; Sándor Damjanovich; Jörg Langowski; Katalin Tóth
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

Review 9.  Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis.

Authors:  M Okano
Journal:  Clin Exp Immunol       Date:  2009-08-06       Impact factor: 4.330

10.  Receptor-interacting protein 140 is a repressor of the androgen receptor activity.

Authors:  Sophie Carascossa; Jérôme Gobinet; Virginie Georget; Annick Lucas; Eric Badia; Audrey Castet; Roger White; Jean-Claude Nicolas; Vincent Cavaillès; Stéphan Jalaguier
Journal:  Mol Endocrinol       Date:  2006-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.